Skip to content
HowShorted

Apellis Pharmaceuticals, Inc. short interest in 2020

In 2020, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 13.32% of shares outstanding on 15 Jul 2020 to 11.93% on 31 Dec 2020, a change of -1.39 percentage points. The year's high was 14.41% on 30 Sep 2020 and its low 11.14% on 15 Dec 2020, averaging 13.15% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.90 days on 31 Aug 2020. Full history: Apellis Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Apellis Pharmaceuticals, Inc. in 2020

2020 in figures

Start of year
13.32% (15 Jul 2020)
End of year
11.93% (31 Dec 2020)
Change
-1.39 pp
High
14.41% (30 Sep 2020)
Low
11.14% (15 Dec 2020)
Average
13.15%
Highest days to cover
24.90 (31 Aug 2020)
SEC filings marked
5

Every report in 2020

Apellis Pharmaceuticals, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jul 202013.32%19.12results (8-K), 10-K filed, 10-Q filed
31 Jul 202013.41%12.5910-Q filed
14 Aug 202013.50%18.14
31 Aug 202013.63%24.90
15 Sep 202013.89%21.05
30 Sep 202014.41%19.37
15 Oct 202014.08%21.86
30 Oct 202013.46%21.78
13 Nov 202013.12%17.2010-Q filed
30 Nov 202011.94%14.97
15 Dec 202011.14%10.97
31 Dec 202011.93%12.93

See also: Apellis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.